
Tesamorelin
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog developed to stimulate endogenous growth hormone (GH) secretion. It is FDA-approved for reducing excess abdominal (visceral) fat in patients with HIV-associated lipodystrophy. By increasing GH and IGF-1 levels, Tesamorelin promotes lipolysis while preserving lean body mass. It is also being investigated for broader metabolic and fat-reduction benefits, including potential applications in non-HIV-related obesity and non-alcoholic fatty liver disease (NAFLD).
For laboratory research use only. Not for human or animal consumption.
- 110% OFFYour first order
Use code DYNASTY at checkout.
Enter code DYNASTY at checkout - 2FREE SHIPPINGOn orders over $99
Applied automatically at checkout. U.S. orders only.
Spend $99.00 for free shipping - 3BUY 3, GET 1 FREESame peptide & size
Add 4 of the same item — get the 4th one free.
Add 4 of the same item for one free
- Primary Research Areas:
- FDA-approved treatment for HIV-associated lipodystrophy
- Reduction of visceral adipose tissue (VAT)
- Investigational fat loss in non-HIV individuals
- Preservation of lean body mass during fat reduction
- Improvement of lipid profiles
- Reduction of liver fat and management of NAFLD
- Potential protection against age-related muscle loss
